Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy.

Fong L, Brockstedt D, Benike C, Breen JK, Strang G, Ruegg CL, Engleman EG.

J Immunol. 2001 Dec 15;167(12):7150-6.

2.

Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.

Burch PA, Breen JK, Buckner JC, Gastineau DA, Kaur JA, Laus RL, Padley DJ, Peshwa MV, Pitot HC, Richardson RL, Smits BJ, Sopapan P, Strang G, Valone FH, Vuk-Pavlović S.

Clin Cancer Res. 2000 Jun;6(6):2175-82.

Supplemental Content

Loading ...
Support Center